Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andreas Dominik Braun

Professor for Digital and Molecular Dermatopathology

University of Lübeck

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (12)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (4)

Thomas Tüting

Director

University Hospital Magdeburg

GERMANY

View details

Julia Maria Ressler

Medical University of Vienna

AUSTRIA

View details

Denny Schanze

Institute of Human Genetics

GERMANY

View details

Evelyn Gaffal

University Hospital Magdeburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Dominik Braun

Research Interests

Explore related searches

Articles (12)

HCA2 Receptors in Lymphocytes and Keratinocytes Affect Murine Contact Allergic Inflammation

Subcutaneous pedicle subunit flap for upper lip reconstruction

Downregulation of MHC-I on Melanoma Cells and Decreased CD8+ T-Cell Infiltration Are Associated With Metastatic Spread and Resistance to Immunotherapy

Liver Metastases are Associated with a Short Post-Progression Survival in a Real-World Group of Patients with Melanoma Treated with Checkpoint Inhibitors

MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression

Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice

Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

Umfassende Analyse des Einflusses der Body Composition auf die Wirksamkeit und das Nebenwirkungsprofil einer Systemtherapie mit Tyrosinkinaseinhibitoren bei Melanompatienten

Acantholytic squamous cell carcinoma in a patient with junctional epidermolysis bullosa

CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumours

Real‐world outcomes using PD ‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Collaborators (4)

Thomas Tüting

Julia Maria Ressler

Denny Schanze

Evelyn Gaffal

Make your next move.